Osamu Ike

816 total citations
35 papers, 611 citations indexed

About

Osamu Ike is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Osamu Ike has authored 35 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Surgery. Recurrent topics in Osamu Ike's work include Lung Cancer Diagnosis and Treatment (8 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Osamu Ike is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Osamu Ike collaborates with scholars based in Japan and United States. Osamu Ike's co-authors include Shigeki Hitomï, Hiromi Wada, Yasuhiko Shimizu, Hiroyasu Yokomise, Hiroshi Mizuno, Tatsuo Fukuse, Yoshito Ikada, Tohru Natsume, Y. Ikada and Toshiki Hirata and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and CHEST Journal.

In The Last Decade

Osamu Ike

31 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Ike Japan 16 198 194 146 139 89 35 611
Rosemary R. Palmer United Kingdom 4 114 0.6× 109 0.6× 80 0.5× 76 0.5× 27 0.3× 6 495
S. Bennis Morocco 15 144 0.7× 94 0.5× 99 0.7× 198 1.4× 20 0.2× 52 600
Ashish Bakshi India 11 63 0.3× 84 0.4× 80 0.5× 127 0.9× 80 0.9× 34 426
Hun Mo Ryoo South Korea 17 113 0.6× 148 0.8× 84 0.6× 371 2.7× 67 0.8× 47 930
Syed M. Gilani United States 12 164 0.8× 102 0.5× 133 0.9× 144 1.0× 18 0.2× 49 578
Kiyohiko Omichi Japan 18 345 1.7× 138 0.7× 69 0.5× 293 2.1× 30 0.3× 33 748
Kazuya Sakata Japan 12 204 1.0× 95 0.5× 143 1.0× 154 1.1× 14 0.2× 39 549
Franco Mattavelli Italy 17 530 2.7× 190 1.0× 64 0.4× 291 2.1× 30 0.3× 42 921
Maria Grazia Zurlo Italy 13 53 0.3× 80 0.4× 140 1.0× 132 0.9× 29 0.3× 19 579
Shin Myung Kang South Korea 13 67 0.3× 278 1.4× 94 0.6× 181 1.3× 12 0.1× 26 531

Countries citing papers authored by Osamu Ike

Since Specialization
Citations

This map shows the geographic impact of Osamu Ike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Ike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Ike more than expected).

Fields of papers citing papers by Osamu Ike

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Ike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Ike. The network helps show where Osamu Ike may publish in the future.

Co-authorship network of co-authors of Osamu Ike

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Ike. A scholar is included among the top collaborators of Osamu Ike based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Ike. Osamu Ike is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tamura, Takashi, Jun Imai, Akihiro Matsumoto, et al.. (2002). Organ distribution of cisplatin after intraperitoneal administration of cisplatin-loaded microspheres. European Journal of Pharmaceutics and Biopharmaceutics. 54(1). 1–7. 25 indexed citations
2.
Chen, Fengshi, Osamu Ike, Hiromi Wada, & Shigeki Hitomï. (2000). Pulmonary mucosa-associated lymphoid tissue lymphoma 8 years after resection of the same type of lymphoma of the liver. The Japanese Journal of Thoracic and Cardiovascular Surgery. 48(4). 233–235. 22 indexed citations
3.
Oka, Takashi, Yukako Yoshikawa, Nobuhito Shibata, et al.. (1999). Pharmacokinetics of cisplatin in analbuminemic rats. Biopharmaceutics & Drug Disposition. 20(9). 421–428. 21 indexed citations
4.
Chen, Fengshi, Toru Bando, Nobuharu Hanaoka, et al.. (1999). Mediastinal Thoracic Duct Cyst. CHEST Journal. 115(2). 584–585. 15 indexed citations
5.
Yokomise, H., Yoshifumi Nishimura, Tatsuo Fukuse, et al.. (1998). Long-Term Remission after Brachytherapy with External Irradiation for Locally Advanced Lung Cancer. Respiration. 65(6). 489–491. 7 indexed citations
6.
Yokomise, Hiroyasu, Hiroshi Mizuno, Osamu Ike, et al.. (1998). Importance of Intrapulmonary Lymph Nodes in the Differential Diagnosis of Small Pulmonary Nodular Shadows. CHEST Journal. 113(3). 703–706. 35 indexed citations
7.
Yagi, Kazuyuki, Toshiki Hirata, Tatsuo Fukuse, et al.. (1996). Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded. The Annals of Thoracic Surgery. 61(2). 521–524. 77 indexed citations
8.
Wada, Hiromi, Fumihiro Tanaka, Kazuhiro Yanagihara, et al.. (1996). Time trends and survival after operations for primary lung cancer from 1976 through 1990. Journal of Thoracic and Cardiovascular Surgery. 112(2). 349–355. 46 indexed citations
9.
Inui, Kenji, Hiroyasu Yokomise, Osamu Ike, et al.. (1996). Floating object in pleural space, a precursor of thoracolithiasis; a case report.. The Journal of the Japanese Association for Chest Surgery. 10(1). 52–56. 6 indexed citations
10.
Wada, Hiromi, Hiroyasu Yokomise, Fumihiro Tanaka, et al.. (1995). Surgical treatment of small cell carcinoma of the lung: advantage of preoperative chemotherapy. Lung Cancer. 13(1). 45–56. 19 indexed citations
11.
Okubo, Kyohei, Hideyuki Wada, Tatsuo Fukuse, et al.. (1995). Treatment of Pancoast Tumors. The Thoracic and Cardiovascular Surgeon. 43(5). 284–286. 32 indexed citations
12.
Tanaka, Fumihiro, Hironobu Wada, Ken‐ichi Inui, et al.. (1995). Pulmonary Metastasis of Polymorphous Low-Grade Adenocarcinoma of the Minor Salivery Gland. The Thoracic and Cardiovascular Surgeon. 43(3). 178–180. 27 indexed citations
13.
Ike, Osamu, Suong Hyu Hyon, Shigeki Hitomï, et al.. (1994). Treatment of malignant pleural effusion using cisplatin-containing PGLA microspheres.. Drug Delivery System. 9(6). 437–441.
14.
Natsume, Tohru, et al.. (1993). Porous collagen sponge for esophageal replacement. Journal of Biomedical Materials Research. 27(7). 867–875. 59 indexed citations
15.
Ike, Osamu, Yoichi Shimizu, R. Wada, Suong‐Hyu Hyon, & Y. Ikada. (1992). Controlled cisplatin delivery system using poly(d,l-lactic acid]. Biomaterials. 13(4). 230–234. 48 indexed citations
16.
Ike, Osamu, et al.. (1991). Histopathological Changes in Invasive Thymoma in Patients with Recurrence. The Thoracic and Cardiovascular Surgeon. 39(4). 228–231. 1 indexed citations
17.
Ike, Osamu, Yasuhiko Shimizu, Yoshito Ikada, et al.. (1991). Biodegradation and antitumour effect of adriamycin-containing poly(l-lactic acid) microspheres. Biomaterials. 12(8). 757–762. 22 indexed citations
18.
Ike, Osamu, Yasuhiko Shimizu, Shigeki Hitomï, Ryoichi Wada, & Yoshito Ikada. (1991). Treatment of Malignant Pleural Effusions with Doxorubicin Hydrochloride-Containing Poly(L-Lactic Acid) Microspheres. CHEST Journal. 99(4). 911–915. 26 indexed citations
19.
Ike, Osamu, et al.. (1990). Cis-diamminedichloroplatinum delivery system using poly (lactic acid).. Drug Delivery System. 5(1). 29–32. 5 indexed citations
20.
Ike, Osamu, et al.. (1982). . Haigan. 22(2). 139–151. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026